BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29129086)

  • 1. The management of localized esophageal squamous cell carcinoma: Western approach.
    Zaidi N; Kelly RJ
    Chin Clin Oncol; 2017 Oct; 6(5):46. PubMed ID: 29129086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genomic characterization of oesophageal carcinoma.
    ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Nature; 2017 Jan; 541(7636):169-175. PubMed ID: 28052061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies.
    Testa U; Castelli G; Pelosi E
    Curr Oncol; 2023 Jan; 30(1):610-640. PubMed ID: 36661697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
    He SY; Wang XB; Jiao YC
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):517-522. PubMed ID: 30060360
    [No Abstract]   [Full Text] [Related]  

  • 9. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
    Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
    BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in treating oesophageal cancer.
    Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA
    F1000Res; 2020; 9():. PubMed ID: 33042518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to Localized Squamous Cell Cancer of the Esophagus.
    Weidenbaum C; Gibson MK
    Curr Treat Options Oncol; 2022 Oct; 23(10):1370-1387. PubMed ID: 36042147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
    Sun N; Ye L; Chang T; Li X; Li X
    Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets.
    Mei LL; Qiu YT; Zhang B; Shi ZZ
    Cancer Biomark; 2017; 19(1):1-9. PubMed ID: 28269750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.
    Adachi Y; Ohashi H; Imsumran A; Yamamoto H; Matsunaga Y; Taniguchi H; Nosho K; Suzuki H; Sasaki Y; Arimura Y; Carbone DP; Imai K; Shinomura Y
    Tumour Biol; 2014 Feb; 35(2):973-85. PubMed ID: 24026884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
    Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
    Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal Cancer Genetics and Clinical Translation.
    Jajosky A; Fels Elliott DR
    Thorac Surg Clin; 2022 Nov; 32(4):425-435. PubMed ID: 36266030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Liu Z; Yang T; Xu Z; Cao X
    Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma.
    Bandla S; Pennathur A; Luketich JD; Beer DG; Lin L; Bass AJ; Godfrey TE; Litle VR
    Ann Thorac Surg; 2012 Apr; 93(4):1101-6. PubMed ID: 22450065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.